Godavari Drugs Ltd

Mon 7/09/2026,14:42:0 | BSE : GODAVARI

₹113.257.24 (6.83%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 107.10

Previous Close

₹ 106.01

Volume

8169

Mkt Cap ( ₹ Cr)

₹ 114.69

High

₹ 114.50

Low

₹ 107.10

52 Week High

₹ 135.25

52 Week Low

₹ 69.70

Book Value Per Share

₹ 75.94

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Godavari Drugs Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Godavari Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Godavari Drugs - Intimation Of Dispatch Of Physical Letters Pursuant To Regulation 36(1)(B) Of The SEBI (LODR) Regulations

    3 Sep 2026, 2:09PM We hereby inform that the company has dispatched a physical letter to the shareholders whose email addresses are not registered with the company/RTA/D
  • Godavari Drugs - Reg. 34 (1) Annual Report.

    1 Sep 2026, 4:55PM The Company informed that the 38th AGM of the Company is scheduled to be held on Friday, the 25th Sep 2026 at 03.00 pm through Video Conferencing/ oth
  • Godavari Drugs - 39Th AGM To Be Held On 25Th Sep 2026 At 11.00 A.M. Through Video Conferencing

    1 Sep 2026, 4:49PM Notice of 38th AGM to be held on 25th Sep 2026 at 03.00 p.m. through Video Conferencing/Other Audio Visual Means in accordance with the relevant circu
  • Godavari Drugs - 38Th AGM To Be Held On 25.09.2026 - Book Closure - 19.09.2026 - 25.09.2026 (Both Days) And Evoting, Cutoff D

    1 Sep 2026, 4:45PM The Register of Members and Share Transfer Books of the Company will remain closed from 19.09.2026 to 25.09.2026 (Both days Inclusive) for taking reco
  • Godavari Drugs - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association

    1 Sep 2026, 11:02AM Amendment to MOA of the company was approved by Board of Directors. The Proposed change in MOA of the company is subject to necessary approvals from M
  • Godavari Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 31.08.2026 - Alteration Of The Main Objects Claus

    31 Aug 2026, 6:57PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we inform that the Board of Directors at its meeting held on 31st August, 2026 approved th
  • Godavari Drugs - Submission Of Statement On Deviation Or Variation In Utilisation Of Funds For The Quarter Ended 30 June 2026

    17 Aug 2026, 11:41AM Submission of Statement on Deviation or Variation in uitilisation of Funds for the quarter ended 30 june 2026
  • Godavari Drugs - Announcement under Regulation 30 (LODR)-Allotment

    14 Aug 2026, 1:06PM Board of Directors of the Company in its meeting held on Friday, 14th August, 2026 at 11.45 A.M. approved and passed the resolution for allotment of E
  • Godavari Drugs - Submission Of Un-Audited Standalone Financial Results For The Quarter Ended As On June 30, 2026

    14 Aug 2026, 1:00PM Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 2026
  • Godavari Drugs - Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2026

    14 Aug 2026, 12:55PM Submission of Un-Audited Standalone Financial Results for the Quarter ended as on June 30, 2026 and Allotment of Equity Shares on conversion of 7,86,6
  • Godavari Drugs - Update on board meeting

    11 Aug 2026, 5:31PM Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and a
  • Godavari Drugs - Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results Of The Company For T

    10 Aug 2026, 7:26PM Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and a
  • Godavari Drugs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 12:40PM As of June 2026, 40.23% is owned by Indian Promoters and 59.77% by Public. <p align=justify> Top five Promoters holding highest number of shares of Go
  • Godavari Drugs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    11 Jul 2026, 9:35AM Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018

Key fundamentals

Evaluate the intrinsic value of Godavari Drugs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 152.1573 104.9738 94.5909 66.9135 49.9747
Liabilities 152.1573 104.9738 94.5909 66.9135 49.9747
Equity 10.1274 7.5305 7.5305 7.5305 7.5305
Gross Profit 10.3146 11.8278 13.3043 9.9208 11.29
Net Profit 4.0891 4.38 5.5489 3.7858 5.2453
Cash From Operating Activities 0.7335 11.196 18.4136 13.2171 11.2298
NPM(%) 3.86 3.86 3.54 2.37 3.25
Revenue 105.8081 113.3501 156.7119 159.6248 161.1062
Expenses 95.4935 101.5223 143.4076 149.704 149.8162
ROE(%) 5.31 5.69 7.21 4.92 6.82

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Godavari Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 875.00 1.94 22.00 60.50 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 108.55 1.12 1561.43 220.46 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.34 0.00 0.00 457.75 -39.50 0.00
Astec Lifesciences Ltd 554.90 -0.08 0.00 236.21 -363.14 0.00

Company Info

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

GODAVARI DRUGS LIMITED was incorporated as a private limited company on December 2nd 1987 and subsequently converted into a public limited company on September 25th 1992. It was promoted by Mr. Ghanshyam Jaju, Mr. Mukund Kakani and Mr. P.C. Shrimal. The company has set up a project to manufacture 180 TPA at SULPHAMETHOXAZOLE (SMX) in 1988. The project is located at Maharashtra Industrial Development Corporation (MIDC), Nanded, a notified class 'C' backward district in Maharashtra. The project was fully commissioned on July 3rd 1989. MAIN OBJECTS OF THE COMPANY: The main objects at the Company as detailed in the Memorandum at Association of the Company are: 1. To manufacture, refine, purchase, sell, prepare, import, export all classes and kinds of drugs including pharmaceutical preparations and formulations, fine organics and inorganic chemicals, raw materials and intermediates for drugs. 2. To manufacture and/or deal in all types at drugs, chemicals, pharmaceuticals and intermediates on loan licence basis. 3. To undertake, promote, encourage, initiate, assist and engage in all kinds of research and development work and to set up laboratories and other facilities required for the same to render such assistance, monetary or otherwise, as may be required for the purpose. 2012 -Godavari Drugs Ltd has informed that the Board has appointed Mr. Mohit Jaju as an Additional Director effective from May 10, 2012

Parent Organisation

Godavari Drugs Ltd.

Founded

02/12/1987

Managing Director

Mr.Mukund Kakani

NSE Symbol

FAQ